Detection of Mutations and Large Rearrangements of the Low-Density Lipoprotein Receptor Gene in Taiwanese Patients With Familial Hypercholesterolemia

American Journal of Cardiology

Volumn 105, Issue 12, 2010, Pages 1752-1758

  Chiou, Kuan Rau ^a,c   Charng, Min Ji ^b,c  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; EZETIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; ROSUVASTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; DIAGNOSTIC PROCEDURE; EXON; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FRAMESHIFT MUTATION; GENE DELETION; GENE DUPLICATION; GENE MUTATION; GENE REARRANGEMENT; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; NONSENSE MUTATION; PEDIGREE ANALYSIS; PRIORITY JOURNAL; TAIWAN;

ADULT; APOLIPOPROTEINS B; DNA; DNA MUTATIONAL ANALYSIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INCIDENCE; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PREVALENCE; RECEPTORS, LDL; SERINE ENDOPEPTIDASES; TAIWAN;

EID: 77953584677     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2010.01.356     Document Type: Article

References (28)

1. Rader D.J., Cohen J., and Hobbs H.H. Monogenic hypercholesterolemia: new insights in pathogenesis and treatment. J Clin Invest 111 (2003) 1795-1803
2. Scientific Steering Committee on Behalf of the Simon Broome Register Group. Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Atherosclerosis 142 (1999) 105-112
3. Hobbs H.H., Russell D.W., Brown M.S., and Goldstein J.L. The LDL receptor locus in familial hypercholesterolemia: mutational analysis of a membrane protein. Annu Rev Genet 24 (1990) 133-170
4. Goldstein J.L., Hobbs H.H., and Brown M.S. Familial hypercholesterolemia. In: Scriver C.R., Beaudet A.L., Sly W.S., and Valle D. (Eds). The Metabolic Basis of Inherited (2001), McGraw-Hill, New York 2863-2913
5. Soria L.F., Ludwig E.H., Clarke H.R., Vega G.L., Grundy S.M., and McCarthy B.J. Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100. Proc Natl Acad Sci U S A 86 (1989) 587-591
6. Abifadel M., Varret M., Rabes J.P., Allard D., Ouguerram K., Devillers M., Cruaud C., Benjannet S., Wickham L., Erlich D., Derré A., Villéger L., Farnier M., Beucler I., Bruckert E., Chambaz J., Chanu B., Lecerf J.M., Luc G., Moulin P., Weissenbach J., Prat A., Krempf M., Junien C., Seidah N.G., and Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet 34 (2003) 154-156
7. Wang J., Ban M.R., and Hegele R.A. Multiplex ligation-dependent probe amplification of LDLR enhances molecular diagnosis of familial hypercholesterolemia. J Lipid Res 46 (2005) 366-372
8. Sellner L.N., and Taylor G.R. MLPA and MAPH: new techniques for detection of gene deletions. Hum Mutat 23 (2004) 413-419
9. Tosi I., Toledo-Leiva P., Neuwirth C., Naoumova R.P., and Soutar A.K. Genetic defects causing familial hypercholesterolaemia: identification of deletions and duplications in the LDL-receptor gene and summary of all mutations found in patients attending the Hammersmith Hospital Lipid Clinic. Atherosclerosis 194 (2007) 102-111
10. Sun X.M., Patel D.D., Webb J.C., Knight B.L., Fan L.M., Cai H.J., and Soutar A.K. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arterioscler Thromb 14 (1994) 85-94
11. Chang J.H., Pan J.P., Tai D.Y., Huang A.C., Li P.H., Ho H.L., Hsieh H.L., Chou S.C., Lin W.L., Lo E., Chang C.Y., Tseng J., Su M.T., and Lee-Chen G.J. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese. J Lipid Res 44 (2003) 1850-1858
12. Chiu C.Y., Wu Y.C., Jenq S.F., and Jap T.S. Mutations in low-density lipoprotein receptor gene as a cause of hypercholesterolemia in Taiwan. Metabolism 54 (2005) 1082-1086
13. Yang K.C., Su Y.N., Shew J.Y., Yang K.Y., Tseng W.K., Wu C.C., and Lee Y.T. LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population. J Formos Med Assoc 106 (2007) 799-807
14. Charng M.J., Chiou K.R., Chang H.M., Cheng H.M., Ye Z.X., and Lin S.J. Identification and characterization of novel low-density lipoprotein receptor mutations of familial hypercholesterolaemia patients in Taiwan. Eur J Clin Invest 36 (2006) 866-874
15. Scientific Steering Committee on behalf of the Simon Broome Register Group. Risk of fatal coronary heart disease in familial hypercholesterolaemia. BMJ 303 (1991) 893-896
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. MRC-Holland. Welcome to the MLPA website!. http://www.mrc-holland.com Accessed on September, 2009
18. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
19. Lin M., Chu C.C., Chang S.L., Lee H.L., Loo J.H., Akaza T., Juji T., Ohashi J., and Tokunaga K. The origin of Minnan and Hakka, the so-called "Taiwanese," inferred by HLA study. Tissue Antigens 57 (2001) 192-199
20. Taylor A., Martin B., Wang D., Patel K., Humphries S.E., and Norbury G. Multiplex ligation-dependent probe amplification analysis to screen for deletions and duplications of the LDLR gene in patients with familial hypercholesterolaemia. Clin Genet 76 (2009) 69-75
21. Holla Ø.L., Teie C., Berge K.E., and Leren T.P. Identification of deletions and duplications in the low density lipoprotein receptor gene by MLPA. Clin Chim Acta 356 (2005) 164-171
22. Amsellem S., Briffaut D., Carrié A., Rabès J.P., Girardet J.P., Fredenrich A., Moulin P., Krempf M., Reznik Y., Vialettes B., de Gennes J.L., Brukert E., and Benlian P. Intronic mutations outside of Alu-repeat-rich domains of the LDL receptor gene are a cause of familial hypercholesterolemia. Hum Genet 111 (2002) 501-510
23. Graham I., Atar D., Borch-Johnsen K., Boysen G., Burell G., Cifkova R., Dallongeville J., De Backer G., Ebrahim S., Gjelsvik B., Herrmann-Lingen C., Hoes A., Humphries S., Knapton M., Perk J., Priori S.G., Pyorala K., Reiner Z., Ruilope L., Sans-Menendez S., Op Reimer W.S., Weissberg P., Wood D., Yarnell J., Zamorano J.L., and ESC Committee for Practice Guidelines. European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Atherosclerosis 194 (2007) 1-45
24. Fouchier S.W., Kastelein J.J., and Defesche J.C. Update of the molecular basis of familial hypercholesterolemia in The Netherlands. Hum Mutat 26 (2005) 550-556
25. Dedoussis G.V., Schmidt H., and Genschel J. LDL-receptor mutations in Europe. Hum Mutat 24 (2004) 443-459
26. Dedoussis G.V., Skoumas J., Pitsavos C., Choumerianou D.M., Genschel J., Schmidt H., and Stefanadis C. FH clinical phenotype in Greek patients with LDL-R defective vs. negative mutations. Eur J Clin Invest 34 (2004) 402-409
27. Yamamoto T., Davis C.G., Brown M.S., Schneider W.J., Casey M.L., Golsterin J.L., and Russell D.W. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39 (1984) 27-38
28. Villeger L., Abifadel M., Allard D., Rabes J.P., Thiart R., Kotze M.J., Béroud C., Junien C., Boileau C., and Varret M. The UMD-LDLR database: additions to the software and 490 new entries to the database. Hum Mutat 20 (2002) 81-87